Dianthus Therapeutics Reaches Analyst Target PriceETF Channel • about 2 months agoIn recent trading, shares of Dianthus Therapeutics Inc (DNTH) have crossed above the average analyst 12-month target price of 31.80, changing hands for 31.94/share. When a stock reaches...